The goal of genetic cancer risk assessment is to help identify individuals and families who have a genetic predilection to cancer, and recommend preventative or screening measures to reduce their risk.[4] The discovery of PARP inhibitors as effective treatment for BRCA1/2-associated breast and ovarian cancers has also augmented the role of genetic cancer risk assessment to advise mutation positive patients on specific cancer therapy.[5, 6]. Here, BRCA1 is linked to cancer.